 | • レポートコード：MRC2-11QY04698 • 出版社/出版日：QYResearch / 2020年11月20日 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、93ページ • 納品方法：Eメール（納期：2~3日） • 産業分類：ヘルスケア |
| Single User | ￥546,000 (USD3,900) | ▷ お問い合わせ |
| Multi User | ￥819,000 (USD5,850) | ▷ お問い合わせ |
| Enterprise License | ￥1,092,000 (USD7,800) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 当調査資料は特殊医薬品流通のグローバル市場について調査・分析したレポートです。種類別（腫瘍、関節リウマチ、多発性硬化症、血友病、その他）市場規模、用途別（病院・診療所、薬局、その他）市場規模、地域別（北米、米国、カナダ、ヨーロッパ、ドイツ、フランス、イギリス、イタリア、ロシア、アジア、日本、中国、韓国、インド、オーストラリア、台湾、中南米、メキシコ、ブラジル、アルゼンチン、中東・アフリカ、トルコ、サウジアラビア、UAE等）市場規模データ、主な企業情報と企業別市場シェア等が収録されています。 ・調査範囲 ・エグゼクティブサマリー ・企業別特殊医薬品流通の競争状況、市場シェア ・世界の特殊医薬品流通市場：種類別市場規模 2015年-2020年（腫瘍、関節リウマチ、多発性硬化症、血友病、その他） ・世界の特殊医薬品流通市場：種類別市場規模予測 2021年-2026年（腫瘍、関節リウマチ、多発性硬化症、血友病、その他） ・世界の特殊医薬品流通市場：用途別市場規模 2015年-2020年（病院・診療所、薬局、その他） ・世界の特殊医薬品流通市場：用途別市場規模予測 2021年-2026年（病院・診療所、薬局、その他） ・北米の特殊医薬品流通市場分析：米国、カナダ ・ヨーロッパの特殊医薬品流通市場分析：ドイツ、フランス、イギリス、イタリア、ロシア等 ・アジアの特殊医薬品流通市場分析：日本、中国、韓国、インド、オーストラリア、台湾等 ・中南米の特殊医薬品流通市場分析：メキシコ、ブラジル、アルゼンチン等 ・中東・アフリカの特殊医薬品流通市場分析：トルコ、サウジアラビア、UAE等 ・企業情報（企業概要、製品概要、販売量、企業動向） - 掲載企業（変更可能性あり）：AmerisourceBergen、Mckesson、Cardinal Health、Phoenix、Medipal Holdings、Alliance Healthcare、Sinopharm、Express Scripts、Shanghai Pharma、Anda、Jointown、Max Pharma ・地域別市場規模予測（2021年-2026年）：北米市場、ヨーロッパ市場、アジア市場、中南米市場、中東・アフリカ市場 ・市場機会、課題、リスク、環境分析 ・バリューチェーン、販売チャネル分析 ・調査の結論 |
Specialty Drug Distribution is a link of pharmaceutical logistics; it distributes Specialty Drug to consumers relying on certain logistics equipment, technology and logistics management information system. Specialty drugs play an increasingly important role in the treatment of chronic conditions such as multiple sclerosis (MS), rheumatoid arthritis (RA), psoriasis, and inflammatory bowel disease (IBD), etc.
The type of specialty drugs includes tumor, rheumatoid arthritis, multiple sclerosis, hemophilia and others. The proportion of tumor drugs in 2019 is about 51.56%, and the proportion of rheumatoid arthritis drug in 2019 is about 12.52%.
Specialty drugs are widely sold by hospitals, clinics, pharmacies and others. The most proportion of specialty drugs are sold by hospitals & clinics and the revenue share in 2019 is about 47.05%.
North America region is the largest supplier of specialty drug distribution, with a sales revenue market share nearly 57.08% in 2019. Europe is the second largest supplier, enjoying sales revenue market share about 17.76% in 2019.
Market competition is intense between the giant, Amerisource, Mckesson, Cardinal Health, etc. are the leaders of the industry in North America, PHOENIX, Alliance Healthcare, etc. are the leaders of the industry in Europe and they hold key technologies and patents, with high-end customers; have been formed in the monopoly position in the industry.
Market Analysis and Insights: Global Specialty Drug Distribution Market
The global Specialty Drug Distribution market size is projected to reach US$ 402860 million by 2026, from US$ 243770 million in 2020, at a CAGR of 10.6% during 2021-2026.
With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Specialty Drug Distribution market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global Specialty Drug Distribution market in terms of revenue.
On the whole, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global Specialty Drug Distribution market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global Specialty Drug Distribution market.
Global Specialty Drug Distribution Scope and Market Size
Specialty Drug Distribution market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global Specialty Drug Distribution market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2015-2026.
Market segment by Type, the product can be split into
Oncology
Rheumatoid Arthritis
Multiple Sclerosis
Hemophilia
Others
Market segment by Application, split into
Hospital & Clinic
Pharmacy
Others
Based on regional and country-level analysis, the Specialty Drug Distribution market has been segmented as follows:
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Nordic
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia-Pacific
Latin America
Mexico
Brazil
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of Middle East & Africa
In the competitive analysis section of the report, leading as well as prominent players of the global Specialty Drug Distribution market are broadly studied on the basis of key factors. The report offers comprehensive analysis and accurate statistics on revenue by the player for the period 2015-2020. It also offers detailed analysis supported by reliable statistics on price and revenue (global level) by player for the period 2015-2020.
The key players covered in this study
AmerisourceBergen
Mckesson
Cardinal Health
Phoenix
Medipal Holdings
Alliance Healthcare
Sinopharm
Express Scripts
Shanghai Pharma
Anda
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Specialty Drug Distribution Market Size Growth Rate by Type: 2020 VS 2026
1.2.2 Oncology
1.2.3 Rheumatoid Arthritis
1.2.4 Multiple Sclerosis
1.2.5 Hemophilia
1.2.6 Others
1.3 Market by Application
1.3.1 Global Specialty Drug Distribution Market Share by Application: 2020 VS 2026
1.3.2 Hospital & Clinic
1.3.3 Pharmacy
1.3.4 Others
1.4 Study Objectives
1.5 Years Considered
2 Global Growth Trends
2.1 Global Specialty Drug Distribution Market Perspective (2015-2026)
2.2 Global Specialty Drug Distribution Growth Trends by Regions
2.2.1 Specialty Drug Distribution Market Size by Regions: 2015 VS 2020 VS 2026
2.2.2 Specialty Drug Distribution Historic Market Share by Regions (2015-2020)
2.2.3 Specialty Drug Distribution Forecasted Market Size by Regions (2021-2026)
2.3 Industry Trends and Growth Strategy
2.3.1 Market Trends
2.3.2 Market Drivers
2.3.3 Market Challenges
2.3.4 Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Specialty Drug Distribution Players by Market Size
3.1.1 Global Top Specialty Drug Distribution Players by Revenue (2015-2020)
3.1.2 Global Specialty Drug Distribution Revenue Market Share by Players (2015-2020)
3.2 Global Specialty Drug Distribution Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Players Covered: Ranking by Specialty Drug Distribution Revenue
3.4 Global Specialty Drug Distribution Market Concentration Ratio
3.4.1 Global Specialty Drug Distribution Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Specialty Drug Distribution Revenue in 2019
3.5 Key Players Specialty Drug Distribution Area Served
3.6 Key Players Specialty Drug Distribution Product Solution and Service
3.7 Date of Enter into Specialty Drug Distribution Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Specialty Drug Distribution Breakdown Data by Type (2015-2026)
4.1 Global Specialty Drug Distribution Historic Market Size by Type (2015-2020)
4.2 Global Specialty Drug Distribution Forecasted Market Size by Type (2021-2026)
5 Specialty Drug Distribution Breakdown Data by Application (2015-2026)
5.1 Global Specialty Drug Distribution Historic Market Size by Application (2015-2020)
5.2 Global Specialty Drug Distribution Forecasted Market Size by Application (2021-2026)
6 North America
6.1 North America Specialty Drug Distribution Market Size (2015-2026)
6.2 North America Specialty Drug Distribution Market Size by Type (2015-2020)
6.3 North America Specialty Drug Distribution Market Size by Application (2015-2020)
6.4 North America Specialty Drug Distribution Market Size by Country (2015-2020)
6.4.1 United States
6.4.2 Canada
7 Europe
7.1 Europe Specialty Drug Distribution Market Size (2015-2026)
7.2 Europe Specialty Drug Distribution Market Size by Type (2015-2020)
7.3 Europe Specialty Drug Distribution Market Size by Application (2015-2020)
7.4 Europe Specialty Drug Distribution Market Size by Country (2015-2020)
7.4.1 Germany
7.4.2 France
7.4.3 U.K.
7.4.4 Italy
7.4.5 Russia
7.4.6 Nordic
7.4.7 Rest of Europe
8 China
8.1 China Specialty Drug Distribution Market Size (2015-2026)
8.2 China Specialty Drug Distribution Market Size by Type (2015-2020)
8.3 China Specialty Drug Distribution Market Size by Application (2015-2020)
8.4 China Specialty Drug Distribution Market Size by Region (2015-2020)
8.4.1 China
8.4.2 Japan
8.4.3 South Korea
8.4.4 Southeast Asia
8.4.5 India
8.4.6 Australia
8.4.7 Rest of Asia-Pacific
9 Japan
9.1 Japan Specialty Drug Distribution Market Size (2015-2026)
9.2 Japan Specialty Drug Distribution Market Size by Type (2015-2020)
9.3 Japan Specialty Drug Distribution Market Size by Application (2015-2020)
9.4 Japan Specialty Drug Distribution Market Size by Country (2015-2020)
9.4.1 Mexico
9.4.2 Brazil
.4 Specialty Drug Distribution Market Size by Country (2015-2020)
10.4.1 Turkey
10.4.2 Saudi Arabia
10.4.3 UAE
10.4.4 Rest of Middle East & Africa
10 Key Players Profiles
10.1 AmerisourceBergen
10.1.1 AmerisourceBergen Company Details
10.1.2 AmerisourceBergen Business Overview
10.1.3 AmerisourceBergen Specialty Drug Distribution Introduction
10.1.4 AmerisourceBergen Revenue in Specialty Drug Distribution Business (2015-2020))
10.1.5 AmerisourceBergen Recent Development
10.2 Mckesson
10.2.1 Mckesson Company Details
10.2.2 Mckesson Business Overview
10.2.3 Mckesson Specialty Drug Distribution Introduction
10.2.4 Mckesson Revenue in Specialty Drug Distribution Business (2015-2020)
10.2.5 Mckesson Recent Development
10.3 Cardinal Health
10.3.1 Cardinal Health Company Details
10.3.2 Cardinal Health Business Overview
10.3.3 Cardinal Health Specialty Drug Distribution Introduction
10.3.4 Cardinal Health Revenue in Specialty Drug Distribution Business (2015-2020)
10.3.5 Cardinal Health Recent Development
10.4 Phoenix
10.4.1 Phoenix Company Details
10.4.2 Phoenix Business Overview
10.4.3 Phoenix Specialty Drug Distribution Introduction
10.4.4 Phoenix Revenue in Specialty Drug Distribution Business (2015-2020)
10.4.5 Phoenix Recent Development
10.5 Medipal Holdings
10.5.1 Medipal Holdings Company Details
10.5.2 Medipal Holdings Business Overview
10.5.3 Medipal Holdings Specialty Drug Distribution Introduction
10.5.4 Medipal Holdings Revenue in Specialty Drug Distribution Business (2015-2020)
10.5.5 Medipal Holdings Recent Development
10.6 Alliance Healthcare
10.6.1 Alliance Healthcare Company Details
10.6.2 Alliance Healthcare Business Overview
10.6.3 Alliance Healthcare Specialty Drug Distribution Introduction
10.6.4 Alliance Healthcare Revenue in Specialty Drug Distribution Business (2015-2020)
10.6.5 Alliance Healthcare Recent Development
10.7 Sinopharm
10.7.1 Sinopharm Company Details
10.7.2 Sinopharm Business Overview
10.7.3 Sinopharm Specialty Drug Distribution Introduction
10.7.4 Sinopharm Revenue in Specialty Drug Distribution Business (2015-2020)
10.7.5 Sinopharm Recent Development
10.8 Express Scripts
10.8.1 Express Scripts Company Details
10.8.2 Express Scripts Business Overview
10.8.3 Express Scripts Specialty Drug Distribution Introduction
10.8.4 Express Scripts Revenue in Specialty Drug Distribution Business (2015-2020)
10.8.5 Express Scripts Recent Development
10.9 Shanghai Pharma
10.9.1 Shanghai Pharma Company Details
10.9.2 Shanghai Pharma Business Overview
10.9.3 Shanghai Pharma Specialty Drug Distribution Introduction
10.9.4 Shanghai Pharma Revenue in Specialty Drug Distribution Business (2015-2020)
10.9.5 Shanghai Pharma Recent Development
10.10 Anda
10.10.1 Anda Company Details
10.10.2 Anda Business Overview
10.10.3 Anda Specialty Drug Distribution Introduction
10.10.4 Anda Revenue in Specialty Drug Distribution Business (2015-2020)
10.10.5 Anda Recent Development
10.11 Jointown
10.11.1 Jointown Company Details
10.11.2 Jointown Business Overview
10.11.3 Jointown Specialty Drug Distribution Introduction
10.11.4 Jointown Revenue in Specialty Drug Distribution Business (2015-2020)
10.11.5 Jointown Recent Development
10.12 Max Pharma
10.12.1 Max Pharma Company Details
10.12.2 Max Pharma Business Overview
10.12.3 Max Pharma Specialty Drug Distribution Introduction
10.12.4 Max Pharma Revenue in Specialty Drug Distribution Business (2015-2020)
10.12.5 Max Pharma Recent Development
11 Analyst’s Viewpoints/Conclusions
12 Appendix
12.1 Research Methodology
12.1.1 Methodology/Research Approach
12.1.2 Data Source
12.2 Disclaimer
12.3 Author Details
Table 1. Global Specialty Drug Distribution Market Size Growth Rate by Type (US$ Million): 2020 VS 2026
Table 3. Key Players of Oncology
Table 4. Key Players of Rheumatoid Arthritis
Table 5. Key Players of Multiple Sclerosis
Table 6. Key Players of Hemophilia
Table 7. Key Players of Others
Table 8. Global Specialty Drug Distribution Market Size Growth by Application (US$ Million): 2020 VS 2026
Table 9. Global Specialty Drug Distribution Market Size by Regions (US$ Million): 2020 VS 2026
Table 10. Global Specialty Drug Distribution Market Size by Regions (2015-2020) (US$ Million)
Table 11. Global Specialty Drug Distribution Market Share by Regions (2015-2020)
Table 12. Global Specialty Drug Distribution Forecasted Market Size by Regions (2021-2026) (US$ Million)
Table 13. Global Specialty Drug Distribution Market Share by Regions (2021-2026)
Table 14. Specialty Drug Distribution Market Market Trends
Table 15. Specialty Drug Distribution Market Drivers
Table 16. Specialty Drug Distribution Market Challenges
Table 17. Specialty Drug Distribution Market Restraints
Table 18. Global Specialty Drug Distribution Revenue by Players (2015-2020) (US$ Million)
Table 19. Global Specialty Drug Distribution Market Share by Players (2015-2020)
Table 20. Global Top Specialty Drug Distribution Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Specialty Drug Distribution as of 2019)
Table 21. Global Specialty Drug Distribution by Players Market Concentration Ratio (CR5 and HHI)
Table 22. Key Players Headquarters and Area Served
Table 23. Key Players Specialty Drug Distribution Product Solution and Service
Table 24. Mergers & Acquisitions, Expansion Plans
Table 25. Global Specialty Drug Distribution Market Size by Type (2015-2020) (US$ Million)
Table 26. Global Specialty Drug Distribution Market Size Share by Type (2015-2020)
Table 27. Global Specialty Drug Distribution Revenue Market Share by Type (2021-2026)
Table 28. Global Specialty Drug Distribution Market Size Share by Application (2015-2020)
Table 29. Global Specialty Drug Distribution Market Size by Application (2015-2020) (US$ Million)
Table 30. Global Specialty Drug Distribution Market Size Share by Application (2021-2026)
Table 31. North America Specialty Drug Distribution Market Size by Type (2015-2020) (US$ Million)
Table 32. North America Specialty Drug Distribution Market Share by Type (2015-2020)
Table 33. North America Specialty Drug Distribution Market Size by Application (2015-2020) (US$ Million)
Table 34. North America Specialty Drug Distribution Market Share by Application (2015-2020)
Table 35. North America Specialty Drug Distribution Market Size by Country (US$ Million) (2015-2020)
Table 36. North America Specialty Drug Distribution Market Share by Country (2015-2020)
Table 37. Europe Specialty Drug Distribution Market Size by Type (2015-2020) (US$ Million)
Table 38. Europe Specialty Drug Distribution Market Share by Type (2015-2020)
Table 39. Europe Specialty Drug Distribution Market Size by Application (2015-2020) (US$ Million)
Table 40. Europe Specialty Drug Distribution Market Share by Application (2015-2020)
Table 41. Europe Specialty Drug Distribution Market Size by Country (US$ Million) (2015-2020)
Table 42. Europe Specialty Drug Distribution Market Share by Country (2015-2020)
Table 43. China Specialty Drug Distribution Market Size by Type (2015-2020) (US$ Million)
Table 44. China Specialty Drug Distribution Market Share by Type (2015-2020)
Table 45. China Specialty Drug Distribution Market Size by Application (2015-2020) (US$ Million)
Table 46. China Specialty Drug Distribution Market Share by Application (2015-2020)
Table 47. China Specialty Drug Distribution Market Size by Region (US$ Million) (2015-2020)
Table 48. China Specialty Drug Distribution Market Share by Region (2015-2020)
Table 49. Japan Specialty Drug Distribution Market Size by Type (2015-2020) (US$ Million)
Table 50. Japan Specialty Drug Distribution Market Share by Type (2015-2020)
Table 51. Japan Specialty Drug Distribution Market Size by Application (2015-2020) (US$ Million)
Table 52. Japan Specialty Drug Distribution Market Share by Application (2015-2020)
Table 53. Japan Specialty Drug Distribution Market Size by Country (US$ Million) (2015-2020)
Table 54. Japan Specialty Drug Distribution Market Share by Country (2015-2020)
Table 55. Specialty Drug Distribution Market Size by Country (US$ Million) (2015-2020)
Table 56. Specialty Drug Distribution Market Share by Country (2015-2020)
Table 57. AmerisourceBergen Company Details
Table 58. AmerisourceBergen Business Overview
Table 59. AmerisourceBergen Product
Table 60. AmerisourceBergen Revenue in Specialty Drug Distribution Business (2015-2020) (US$ Million)
Table 61. AmerisourceBergen Recent Development
Table 62. Mckesson Company Details
Table 63. Mckesson Business Overview
Table 64. Mckesson Product
Table 65. Mckesson Revenue in Specialty Drug Distribution Business (2015-2020) (US$ Million)
Table 66. Mckesson Recent Development
Table 67. Cardinal Health Company Details
Table 68. Cardinal Health Business Overview
Table 69. Cardinal Health Product
Table 70. Cardinal Health Revenue in Specialty Drug Distribution Business (2015-2020) (US$ Million)
Table 71. Cardinal Health Recent Development
Table 72. Phoenix Company Details
Table 73. Phoenix Business Overview
Table 74. Phoenix Product
Table 75. Phoenix Revenue in Specialty Drug Distribution Business (2015-2020) (US$ Million)
Table 76. Phoenix Recent Development
Table 77. Medipal Holdings Company Details
Table 78. Medipal Holdings Business Overview
Table 79. Medipal Holdings Product
Table 80. Medipal Holdings Revenue in Specialty Drug Distribution Business (2015-2020) (US$ Million)
Table 81. Medipal Holdings Recent Development
Table 82. Alliance Healthcare Company Details
Table 83. Alliance Healthcare Business Overview
Table 84. Alliance Healthcare Product
Table 85. Alliance Healthcare Revenue in Specialty Drug Distribution Business (2015-2020) (US$ Million)
Table 86. Alliance Healthcare Recent Development
Table 87. Sinopharm Company Details
Table 88. Sinopharm Business Overview
Table 89. Sinopharm Product
Table 90. Sinopharm Revenue in Specialty Drug Distribution Business (2015-2020) (US$ Million)
Table 91. Sinopharm Recent Development
Table 92. Express Scripts Business Overview
Table 93. Express Scripts Product
Table 94. Express Scripts Company Details
Table 95. Express Scripts Revenue in Specialty Drug Distribution Business (2015-2020) (US$ Million)
Table 96. Express Scripts Recent Development
Table 97. Shanghai Pharma Company Details
Table 98. Shanghai Pharma Business Overview
Table 99. Shanghai Pharma Product
Table 100. Shanghai Pharma Revenue in Specialty Drug Distribution Business (2015-2020) (US$ Million)
Table 101. Shanghai Pharma Recent Development
Table 102. Anda Company Details
Table 103. Anda Business Overview
Table 104. Anda Product
Table 105. Anda Revenue in Specialty Drug Distribution Business (2015-2020) (US$ Million)
Table 106. Anda Recent Development
Table 107. Jointown Company Details
Table 108. Jointown Business Overview
Table 109. Jointown Product
Table 110. Jointown Revenue in Specialty Drug Distribution Business (2015-2020) (US$ Million)
Table 111. Jointown Recent Development
Table 112. Max Pharma Company Details
Table 113. Max Pharma Business Overview
Table 114. Max Pharma Product
Table 115. Max Pharma Revenue in Specialty Drug Distribution Business (2015-2020) (US$ Million)
Table 116. Max Pharma Recent Development
Table 117. Research Programs/Design for This Report
Table 118. Key Data Information from Secondary Sources
Table 119. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Specialty Drug Distribution Market Share by Type: 2020 VS 2026
Figure 2. Oncology Features
Figure 3. Rheumatoid Arthritis Features
Figure 4. Multiple Sclerosis Features
Figure 5. Hemophilia Features
Figure 6. Others Features
Figure 7. Global Specialty Drug Distribution Market Share by Application: 2020 VS 2026
Figure 8. Hospital & Clinic Case Studies
Figure 9. Pharmacy Case Studies
Figure 10. Others Case Studies
Figure 11. Specialty Drug Distribution Report Years Considered
Figure 12. Global Specialty Drug Distribution Market Size (US$ Million), YoY Growth 2015-2026
Figure 13. Global Specialty Drug Distribution Market Share by Regions: 2020 VS 2026
Figure 14. Global Specialty Drug Distribution Market Share by Regions (2021-2026)
Figure 15. Global Specialty Drug Distribution Market Share by Players in 2019
Figure 16. Global Top Specialty Drug Distribution Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Specialty Drug Distribution as of 2019
Figure 17. The Top 10 and 5 Players Market Share by Specialty Drug Distribution Revenue in 2019
Figure 18. North America Specialty Drug Distribution Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 19. United States Specialty Drug Distribution Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 20. Canada Specialty Drug Distribution Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 21. Europe Specialty Drug Distribution Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 22. Germany Specialty Drug Distribution Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 23. France Specialty Drug Distribution Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 24. U.K. Specialty Drug Distribution Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 25. Italy Specialty Drug Distribution Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 26. Russia Specialty Drug Distribution Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 27. Nordic Specialty Drug Distribution Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 28. Rest of Europe Specialty Drug Distribution Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 29. Asia-Pacific Specialty Drug Distribution Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 30. China Specialty Drug Distribution Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 31. Japan Specialty Drug Distribution Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 32. South Korea Specialty Drug Distribution Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 33. Southeast Asia Specialty Drug Distribution Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 34. India Specialty Drug Distribution Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 35. Australia Specialty Drug Distribution Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 36. Rest of Asia-Pacific Specialty Drug Distribution Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 37. Latin America Specialty Drug Distribution Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 38. Mexico Specialty Drug Distribution Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 39. Brazil Specialty Drug Distribution Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 40. Middle East & Africa Specialty Drug Distribution Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 41. Turkey Specialty Drug Distribution Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 42. Saudi Arabia Specialty Drug Distribution Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 43. UAE Specialty Drug Distribution Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 44. Rest of Middle East & Africa Specialty Drug Distribution Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 45. AmerisourceBergen Revenue Growth Rate in Specialty Drug Distribution Business (2015-2020)
Figure 46. Mckesson Revenue Growth Rate in Specialty Drug Distribution Business (2015-2020)
Figure 47. Cardinal Health Revenue Growth Rate in Specialty Drug Distribution Business (2015-2020)
Figure 48. Phoenix Revenue Growth Rate in Specialty Drug Distribution Business (2015-2020)
Figure 49. Medipal Holdings Revenue Growth Rate in Specialty Drug Distribution Business (2015-2020)
Figure 50. Alliance Healthcare Revenue Growth Rate in Specialty Drug Distribution Business (2015-2020)
Figure 51. Sinopharm Revenue Growth Rate in Specialty Drug Distribution Business (2015-2020)
Figure 52. Express Scripts Revenue Growth Rate in Specialty Drug Distribution Business (2015-2020)
Figure 53. Shanghai Pharma Revenue Growth Rate in Specialty Drug Distribution Business (2015-2020)
Figure 54. Anda Revenue Growth Rate in Specialty Drug Distribution Business (2015-2020)
Figure 55. Jointown Revenue Growth Rate in Specialty Drug Distribution Business (2015-2020)
Figure 56. Max Pharma Revenue Growth Rate in Specialty Drug Distribution Business (2015-2020)
Figure 57. Bottom-up and Top-down Approaches for This Report
Figure 58. Data Triangulation
Figure 59. Key Executives Interviewed
関節リウマチ治療の世界市場（～2026年） Rheumatoid arthritis is a long-term autoimmune disorder that primarily affects joints. The rheumatoid arthritis treatment market is expected to grow over the forecast period owing to the high incidence rate of rheumatoid arthritis among people. Market Analysis and Insights: Global Rheumatoid Arthrit…- 二次性進行型多発性硬化症治療薬の世界市場（～2026年） Market Analysis and Insights: Global Secondary Progressive Multiple Sclerosis Drug Market The global Secondary Progressive Multiple Sclerosis Drug market size is projected to reach US$ XX million by 2026, from US$ XX million in 2020, at a CAGR of XX%% during 2021-2026. Global Secondary Progressive M…
- 血清反応陽性用関節リウマチ治療薬の世界市場（～2026年） Arthritis means inflammation in a joint. The inflammation is characterized by swelling, pain, and redness within the joint. This type of arthritis is known to cause chronic inflammatory disorder in the hands and feet. The Americas dominated the overall market in terms of revenue in 2016 owing to the…
- 関節炎薬の世界市場（～2026年） Arthritis is condition that causes pain and inflammation in joints. Around 100 different types of arthritis related conditions present globally and it is one of the leading cause of disability worldwide. The most common types of arthritis includes: Psoriatic Arthritis, Rheumatoid Arthritis, Osteoart…
- 血友病A治療薬の世界市場（～2026年） Market Analysis and Insights: Global Hemophilia A Drug Market The global Hemophilia A Drug market size is projected to reach US$ XX million by 2026, from US$ XX million in 2020, at a CAGR of XX%% during 2021-2026. Global Hemophilia A Drug Scope and Market Size Hemophilia A Drug market is segmented b…